Teishima, J. et al. 2020. Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors. Canadian Urological Association Journal. 14, 11 (Jun. 2020), E582–7. DOI:https://doi.org/10.5489/cuaj.6413.